Diacarta, Inc.
Hayward, CA
- UEI
- LY4NEL8B8FK9
- CAGE
- 7SGG0
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3857 Breakwater Ave, Hayward, CA 94545, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Reference lab services, vexas syndrome FY26 task order | Veterans Integrated Service Network 21 | $19,104 | |
| Vexas reference lab services FY25 | Veterans Integrated Service Network 21 | $19,104 | |
| Cost per tests | Veterans Integrated Service Network 8 | $39,000 | |
| EO14042-topic 345 - sbir phase II: radtox - measuring radiation toxicity using circulating DNA | National Cancer Institute | $1,999,984 | |
| JAK2 cost per test | Veterans Integrated Service Network 8 | $39,000 |
About Diacarta, Inc.
Diacarta, Inc. is a for-profit corporate entity registered in SAM.gov, located in Hayward, California, with a current registration valid through August 27, 2026. The company specializes in providing reference laboratory services, with a specific focus on advanced medical testing related to rare medical conditions. Based on its federal contract history, Diacarta, Inc. appears to be a specialized medical diagnostics firm that works closely with federal healthcare agencies, particularly within the Veterans Affairs system.
The company has been awarded federal contracts exclusively through the Veterans Integrated Service Network 21 (VISN 21), a civilian agency within the U.S. Department of Veterans Affairs. Specifically, Diacarta, Inc. provides reference lab services focused on VEXAS syndrome, a rare inflammatory disorder. These services involve specialized medical testing, including specimen pickup, testing, reporting, and consultation services for somatic mutations of the UBA1 gene. The contracts have been awarded on a firm fixed-price basis with no specific set-aside designations, indicating open competition. Each contract has a relatively modest ceiling value, ranging from $19,104 for annual task orders to a broader Indefinite Delivery Contract (IDC) with a $200,000 ceiling.
Diacarta, Inc. holds an Indefinite Delivery Contract (IDC) with VISN 21, awarded on October 1, 2024, with an ultimate completion date of September 30, 2029. This single-award IDC is specifically structured for reference lab services related to VEXAS syndrome. Under this IDC, the company has been awarded task orders for fiscal years 2025 and 2026, each with a $19,104 ceiling value. The contract enables VISN 21 to procure specialized laboratory testing services as needed, with a focus on diagnostic testing for a specific rare medical condition. The IDC provides flexibility for the Veterans Affairs system to access Diacarta's specialized medical testing capabilities over a multi-year period.
Quick answers
What is Diacarta, Inc.'s UEI?
Diacarta, Inc.'s Unique Entity ID (UEI) in SAM.gov is LY4NEL8B8FK9.
What is Diacarta, Inc.'s CAGE code?
Diacarta, Inc.'s CAGE code is 7SGG0.
What is Diacarta, Inc.'s primary NAICS code?
Diacarta, Inc.'s primary NAICS code is 621511 (Medical Laboratories).
Where is Diacarta, Inc. located?
Diacarta, Inc.'s physical address in SAM.gov is 3857 Breakwater Ave, Hayward, CA 94545, USA.
Is Diacarta, Inc. registered in SAM.gov?
Yes. Diacarta, Inc.'s SAM.gov registration is active through October 28, 2026.
What is Diacarta, Inc.'s most recent federal award?
Diacarta, Inc.'s most recent federal contract award is Reference lab services, vexas syndrome FY26 task order (36C26126N0140), from Veterans Integrated Service Network 21, on October 1, 2025.
On GovTribe
See Diacarta, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors